CAMBIA
- Product NDC
- 50192-113
- 11-digit product format
- 501920113
- Labeler code
- 50192
- Product ID
- 50192-113_3a38ddb1-2e6b-406e-8992-a1c9cbd9acd0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diclofenac Potassium
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Nautilus Neurosciences, Inc.
- Application
- NDA022165
- Marketing category
- NDA
- Marketing start
- 2010-04-20
- Marketing end
- 0000-00-00
- Substance
- DICLOFENAC POTASSIUM
- Active strength
- 1 mg/mg
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50192-113-01 | CAMBIA | 50 mg in 1 PACKET | POWDER, FOR SOLUTION | 50 | | 4 |
| 50192-113-09 | CAMBIA | 50 mg in 1 PACKET | POWDER, FOR SOLUTION | 50 | | 4 |
| 50192-113-09 | CAMBIA | 09 in 1 BOX | POWDER, FOR SOLUTION | 09 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DICLOFENAC POTASSIUM | ACTIVE INGREDIENT | L4D5UA6CB4 | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| DICLOFENAC | ACTIVE MOIETY | 144O8QL0L1 | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| GLYCERYL BEHENATE | INACTIVE INGREDIENT | R8WTH25YS2 | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| POTASSIUM BICARBONATE | INACTIVE INGREDIENT | HM5Z15LEBN | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50192-113 | CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] | 4 | Legacy NDC, 3 package rows | 20120402_d7335594-50c9-4ae2-a3e3-b9a375187b62.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 50192-113-01 | 50192011301 | 50 mg in 1 PACKET | 50 mg | Historical |
| 50192-113-09 | 50192011309 | 50 mg in 1 PACKET | 50 mg | Historical |